CBD AUTO 30:1 Feminised Seeds

$12.60$45.75

 

Please select pack size below

Clear

We send seeds in discreet stealth packaging worldwide.

We're Social - Spread the Love

CBD AUTO 30:1 Feminised cannabis Seeds by Medical Marijuana Genetics

CBD Auto 30:1 has THC levels at 0.5%, CBD at 17% and a 30:1 ratio resulting in healing and soothing effects without any psychoactive effects at all. Medicinal users will benefit from her high levels of CBD. As a result, sufferers from Alzheimer’s, Anxiety, Autism, Epilepsy, PTSD and Stress should get some relief.

Growing well outdoors where Medical Marijuana Genetics CBD Auto 30:1 Feminised will reach a height between 140 – 160 cm tall. Those who prefer to grow as nature intended can expect yields of around 400 g/plant. However, Indoor plants will be a little shorter, finishing at about 100 – 120 cm. CBD Auto’s life-cycle from seed to harvest is completed within 90 days. In short, allowing for the cultivation of multiple successive crops in warmer climate regions.

These plants display some variation in scent and flavour with high levels of myrcene, limonene and bisabolol. A musky, earthy taste with lemon tones await users.

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death. Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin. Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe. Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio. In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders
Genetics

Pink Kush CBD x Afghani Auto

Variety

Mostly Indica

Flowering Time

90 days from seed

Flowering Type

Autoflowering

Sex

Feminised

THC Content

0.50%

CBD Content

High (5% +)

Yield

Medium

Grows

Grows Indoors, Grows outdoors

Plant Height

Indoors: 100 – 120 cm; Outdoors: 140 – 160 cm.

Medical Conditions

Alzheimer's, Anxiety, Autism, Epilepsy, PTSD, Stress

Medical Properties

Yes

Effect

Calming, Soothing

Flavour

Earthy, Flowery, Lemon, Musky